Monash IVF Group Limited (ASX:MVF)
Australia · Delayed Price · Currency is AUD 0.8500
-0.0200 (-2.30%)
Nov 27, 2025, 4:10 PM AEST
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 331.19 million as of November 26, 2025. Its market cap has decreased by -25.76% in one year.
Market Cap
331.19M
Enterprise Value
506.21M
Revenue
271.92M
Ranking
n/a
PE Ratio
13.28
Stock Price
0.85
Market Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 331.19M, a decrease of -38.04%. That is a compound annual growth rate of -4.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 338.98M | -31.50% |
| Dec 31, 2024 | 494.84M | -2.31% |
| Dec 29, 2023 | 506.53M | 36.13% |
| Dec 30, 2022 | 372.10M | -9.48% |
| Dec 31, 2021 | 411.06M | 34.39% |
| Dec 31, 2020 | 305.86M | 25.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.35B |
| Pro Medicus | 27.17B |
| Cochlear | 18.05B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.27B |
| Ansell | 5.23B |
| Telix Pharmaceuticals | 5.03B |
| Mesoblast | 2.99B |